Clinical Trial Update: Evaluation of Platelet Rich Fibrin on Reduction of Periodontal Problems After Surgical Removal of Mandibular Third Molar [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Platelet-rich fibrin to reduce periodontal problems after surgical removal of the lower third molar.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mastication Disorders
• Periodontal Disease

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Majid Eshghpour | Conditions: Mastication Disorder | Phase 4 | Status: UNKNOWN